Drawing for HANS FARM

USPTO serial 88580989

HANS FARM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KUNKLEMAN, SARAH E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HANS FARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. MacDermott

Michael J. MacDermott LEWIS ROCA ROTHGERBER CHRISTIE LLPP.O. BOX 29001GLENDALE, CA 91209-9001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PLANT EXTRACTS FOR PHARMACEUTICAL PURPOSES; MEDICINAL HERB EXTRACTS; KOREAN HERBAL MEDICINE PREPARATIONS, NAMELY, SCHISANDRA EXTRACTS AND PLUM EXTRACTS; MEDICINAL GINGER EXTRACTS; DIETARY SUPPLEMENTS; HERBS, EXTRACTS AND CONCENTRATES FOR USE AS DIETARY SUPPLEMENTS, NAMELY, BITTER MELON PILLSACTIVE—
029MUDFISH SOUP; LOACH SOUP; SOUPSACTIVE—
031FRESH GINSENG; UNPROCESSED GINSENGACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 29, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 29, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 25, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 21, 2020EX1GSOU EXTENSION 1 GRANTED—
Aug 21, 2020EXT1SOU EXTENSION 1 FILED—
Aug 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 25, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 31, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 21, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Nov 21, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 21, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 21, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 14, 2019DOCKASSIGNED TO EXAMINER—
Sep 3, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 31, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 19, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance